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Objectives: increased levels of various proteinases have been detected in abdominal aortic aneurysms (AAA) and are
assumed to cause the degradation of the aortic wall. To determine whether systemic measurement of these proteinases
and their inhibitors may predict the natural cause of AAA.
Methods and material: serum (S) and plasma (P) samples were obtained from 121 men following the diagnosis of a
small AAA (3–5 cm) at population screening. Annual control scans were performed to check for expansion. Circulating
levels of elastase-alpha1antitrypsin-complexes, alpha1antitrypsin, matrix metalloproteinase (MMP) 2 & 9, tissue-inhibitor-
matrixproteinase 1 & 2, procollagen III-N-terminal-propeptide, and elastin-peptides were measured in a random group
of 36 men.
Results: alpha1antitrypsin was significantly and positively associated with expansion. Similarly, P-MMP9 levels were
significantly associated with size and expansion. There was a difference between median serum and plasma values,
probably because of secretion from platelets.
Conclusion: P-MMP9 and P-alpha1antitrypsin may predict the natural history of AAA.
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Introduction psychological stress.14,15 The results from the U.K. Small
Aneurysm Trial15 seem to confirm these problems. In
Previous reports have described a 0.0–0.5% annual order to make further improvements, development of
additional predictive tools other than size alone arerupture rate of abdominal aortic aneurysms (AAA)
below 5 cm in diameter.1–7 AAA above 5 cm found needed.
The activity and perhaps insufficient inhibition ofat autopsy have an increased risk of rupture with
increasing AAA size; 20–50% risk for AAA 5–7 cm in proteases may cause degradation of the aortic matrix
and subsequent remodelling of elastin and collagendiameter, and a 95% risk for those above 10 cm.1,8,9
These autopsy reports have been confirmed in clinical that leads to aneurysmal formation. Increased levels
of elastase and two matrix metalloproteinases (MMP2studies.3,5–7,10–13 The indication to operate is therefore
determined by the size of the AAA. However, small and MMP9) have been detected in AAA. Consequently,
systemic measurements of these proteases and theirAAA rupture occasionally, while some operated AAA
would never have ruptured. Furthermore, increasing inhibitors may predict the natural history of aneurysms
and allow better selection of patients, i.e. for surgeryuse of ultrasonographic scanning and CT-scanning
has increased the number of small AAA that are or conservative management.
diagnosed. Some will expand to a size which demands
operation, but the patients will then be older, with
increased surgical risk, or may have developed a con-
traindication for operation. Finally, conservative treat- Material and Methods
ment of such small AAA is reported to produce
In 1994, 4404 males aged 65–73 years were invited to
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An AAA was defined by an aortic diameter of 30 mm The trial was approved by the local scientific ethics
committee and reported to the Central Control ofor more. AAAs of 5 cm or more were referred to a
vascular surgeon. AAAs of 3–4.9 cm were offered Registers.
yearly follow-up examinations to check for expansion.
Blood samples were taken, and serum samples were
left for coagulation for 45 min. Plasma was obtained
Resultsby using EDTA as an anticoagulant and platelet free
plasma was prepared. Serum (S) and plasma (P)
Neither the plasma nor the serum levels of elastase-samples were then frozen at −20 °C.
complexes were predictors of AAA size or expansion.Initially, and at the following annual control scans,
However, their major inhibitor, alpha1antitrypsin,two observers and the same scanner were used. The
was significantly and positively associated withobservers used a standardised method for measuring
expansion (Table 1), though the association didthe maximal anteroposterior diameter. Validation of
not increase by summation (S-elastase-complexes+S-the measurements between the two observers is very
alpha1antitrypsin).acceptable.19 We have also reported earlier that the
Concerning the MMP metabolism, P-MMP9 levelsexpansion was more linear than exponential;16 con-
were significantly associated with size and expansion,sequently the mean annual expansion rate was cal-
while MMP2, their common inhibitor, and the ratioculated as: ((Present AP-diameter – Initial AP-
(total MMP/total TIMP) did not predict size or ex-diameter)/days of observation) 365.25 days. The ob-
pansion.servers were blinded to the results from the blood
A large difference between median serum andsamples.
plasma values was observed, probably due to releaseOf the 4404 men who were invited, 3344 (76%)
of these proteases and their protease inhibitors uponattended screening, and of them 141 (4.2%) had AAA.
platelets activation. The finding indicates that furtherOf these, 19 (13.5%) were more than 5 cm. The re-
research could be restricted to platelet-free plasma.maining 122 patients with a small AAA were offered
Consequently, MMP9 analyses were not performed onannual scans. Of these, four (3.3%) died the following
serum (Table 2).year, one (0.8%) was operated on as an emergency
The systemic level of S-elastin peptides was stillbecause of symptoms of aneurysmal rupture, and
predictive of aneurysmal expansion,20 while the level ofseven (5.7%) did not attend for control. At control,
PIIINP-propeptides was not associated to expansion.two (1.8%) proved to be false positives. Thus, 108 men
Neither the ‘‘Matrix Sum’’, defined as S-elastinwith a small AAA had their AAA controlled at a
peptides+S-PIIINP, or the ‘‘Matrix Ratio’’, defined asminimum once. A random sample of 36 cases was
S-elastin peptides/S-NPIIIP, added further predictivesampled after 4 years by the randomisation facility
potentials (Table 3).in Epiinfo version 6.02. No differences between the
Thus, three variables were associated with ex-selected and the unselected cases were noticed con-
pansion. Their non-parametric (Spearman) correlationcerning age and initial AAA size. Concentrations of
coefficients are listed in Table 3.the following were determined: S-alpha1antitrypsin, S-
and P-elastase-alpha1antitrypsin-complexes, S- and P-
matrix metalloproteinase 2 (MMP2) and P-MMP9, S-
and P-tissue-inhibitor-matrixproteinases 1 and 2
Discussion(TIMP1 and 2), and S-elastin-peptides,20 and S-Pro-
collagen III-N-terminal propeptide (PIIINP).21,22
The sample size was chosen because of the sizes ofMMP2, TIMP1, and TIMP2 were measured using en-
kits, and because calculations during the designzyme-linked-immunosorbent assays (ELISA) from
showed that the only two known strong predictors ofAmersham Biotech (Biotrak, Buckinghamshire, U.K.),
the natural history of AAA (S-elastin peptides andwhile MMP9 was determined with a kit from R&D
initial AAA-size) would have been significantly as-Systems (Oxon, U.K.). Between assay coefficients of
sociated with expansion if the sample size and testsvariances in percentages were <10% for all assays. The
were used as in this study, and their association withmethods for elastin-peptides and elastase-alpha-
expansion and AAA size was the same as in one of1antitrypsin-complexes have been reported earlier.20,23
our earlier reports.20 Consequently, we believe thatInitial aneurysm size and mean annual expansion
potential predictors of the natural history of AAArate were compared between those below and those
among the tested variables would be detectable in theabove the median concentrations of the various assays
with Wilcoxon’s rank sum tests. present study.
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Table 1. The association of serum and plasma levels of elastase and alpha1antitrypsin with aneurysmal size and expansion.
Initial AAA size (mm) AAA expansion (mm/year)
Serological marker Median Below Above p Below Above p Correlation
mg/l median median median median coefficient r
S-elastase complexes 13.0 35.6 36.3 0.98 2.91 2.50 0.47
P-elastase-complexes 6.0 33.8 37.9 0.11 1.82 3.47 0.24
P-alpha1-antitrypsin 1390 34.7 37.1 0.32 1.80 3.49 0.05 0.42
(0.08–0.67)
Total-P-alpha1-antitrypsin 1400 34.8 36.9 0.58 2.00 3.42 0.05 0.42
(0.08–0.67)
Alpha1anti-trypsin ratio 0.0046 35.4 36.3 0.92 2.54 2.88 0.85
Total-P-alpha1antitrypsin=P-alpha1antitrypsin+P-elastase-complexes.
Alpha1-antitrypsin-ratio=P-elastase-complexes/P-alpha1antitrypsin.
p: p-value of Wilcoxon’s rank sum test comparing the groups below and above the median value.
r: Spearman’s correlation coefficient (95% confidence limits in parentheses).
Table 2. The association of serum and plasma levels of matrix metalloproteinases (MMP) and tissue-inhibitor-matrixproteinases (TIMP)
with aneurysmal size and expansion.
Initial AAA-size (mm) AAA-expansion (mm/year)
Serological Median Below Above p Below Above p Correlation
marker ng/ml median median median median coefficient r
P-MMP9 60 33.7 38.8 0.04 0.74 3.30 0.01 0.33 ( 0.01–0.53)
S-MMP2 575 36.5 35.8 0.94 2.17 2.00 0.95
P-MMP2 135 35.8 36.1 0.93 2.78 2.60 0.71
S-TIMP1 865 35.5 36.6 0.69 2.68 1.44 0.11
P-TIMP1 336 34.0 37.9 0.10 2.14 3.25 0.48
S-TIMP2 115 38.1 34.5 0.12 3.30 2.26 0.70
P-ratio 1.00 35.6 37.2 0.64 2.72 2.67 0.96
p-ratio=(P-MMP2+P-MMP9)/P-TIMP1.
p: p-value of Wilcoxon’s rank sum test comparing the groups below and above the median value.
r: Spearman’s correlation coefficient (95% confidence limits in parentheses).
Table 3. The association of serum and plasma levels of elastin peptides and procollagen III-N-terminal propeptides (PIIINP) with
aneurysmal size and expansion.
Initial AAA-size (mm) AAA-expansion (mm/year)
Serological Median Below Above p Below Above p Correlation
marker mg/l median median median median coefficient r
S-elastin peptides 330 35.9 36.2 0.90 1.05 3.43 0.01 0.51 (0.20–0.73)
S-PIIINP 320 33.4 36.6 0.61 2.71 1.44 0.18
Matrix sum 640 34.9 37.3 0.31 1.83 3.71 0.04 0.26 (−0.10–.56)
Matrix ratio 1.03 35.5 36.3 0.75 2.26 3.16 0.53
Matrix sum=S-elastin peptides+NPIIIP.
Matrix ratio=S-elastin peptides/NPIIIP.
p: p-value of Wilcoxon’s rank sum test comparing the groups below and above the median value.
r: Spearman’s correlation coefficient (95% confidence limits in parentheses).
Due to the large number of tested variables, and in the complexes did not predict aneurysmal expansion
in this study. This discrepancy between the two ob-order to limit the chance of random significance, the
statistical tests were kept to a minimum, and only servations may be due to the fact that elastase is an
acute phase-reactant reacting on inflammation, andsupported with correlation coefficients in significant
findings. signs of an inflammatory response in so-called
non-inflammatory AAA have been reported.28 Fur-Elastase in blood is immediately inactivated by anti-
proteinases.23 Consequently, these complexes were thermore, the previously observed fourfold increased
levels of elastase in walls of ruptured AAA29 maymeasured instead of elastase activity. Increased levels
of elastase have been noticed in AAA walls,24–27 but be due to the inflammatory response caused by the
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retroperitoneal bleeding.23 Finally, the potential aortic aneurysm size and annual expansion. In this pre-
liminary study, the associations of P-MMP9 and P-derived elastase complexes may be too small in the
alpha1antitrypsin seemed almost as strong as with S-systemic circulation compared to complexes from
elastin-peptides, the most powerful serological pre-other organs, e.g. the lungs, where the complexes
dictor of aneurysmal expansion known. However, aare strongly and negatively correlated to pulmonary
larger sample size is needed to evaluate the potentialfunction.30 On the other hand, the levels of the major
clinical recommendations.systemic elastase inhibitor, alpha1antitrypsine, was
positively associated with expansion. This may be
caused by smoking.30–32 Nevertheless, a predictive
value is possible, but a larger sample size is needed
Acknowledgementsfor clarification and determination of the potential
clinical recommendations.
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P-MMP9 was strongly associated with expansion.
Whether this is a pathogenetic observation remains
unknown, but P-MMP9 seems to be a potential pre-
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